Back to Search Start Over

94-OR

94-OR

Authors :
Hannele Laivuori
Lucilla Poston
Anne Cathrine Staff
M. Moertl
Harald Zeisler
C. Hubel
Claudia Holzman
James M. Roberts
Gayle Olson
E. Schistermann
Ulla Breth Knudsen
David J. Williams
Christopher W.G. Redman
Ignacio Herraiz
Orlaith Burke
Irene Cetin
Thomas F. McElrath
Samantha J. Benton
Stefan Verlohren
D. Schlemback
C. Zhang
Pia M. Villa
P. von Dadelszen
Olav Lapaire
Roberta B. Ness
L. Chapell
L. Oliviera
Eric A.P. Steegers
Vassilis Tsatsaris
Carrie Ris-Stalpers
J. Meyers
Francesc Figueras
Catalin S. Buhimschi
J.A.M. van der Post
S. Timmermans
Holger Stepan
Alberto Galindo
Camilla Kronborg
Pawel Szafranski
Source :
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 5:50-51
Publication Year :
2015
Publisher :
Elsevier BV, 2015.

Abstract

Objectives Circulating placental growth factor (PlGF) is a potential biomarker for preeclampsia. Prior studies show its limited precision in predicting or diagnosing preeclampsia, underscoring a common problem in biomarker data analyses in general – that large studies are needed to overcome clinical heterogeneity and to provide sufficient statistical power. Attaining such sample sizes often requires aggregation of cohorts. Different studies may use disparate platforms for laboratory analyses, complicating data merging. Here, we assessed whether PlGF concentrations could be merged across studies using inter-platform standardization. Methods Of 16516 pregnancies from 23 cohorts, 12,804 had at least one PlGF concentration (gestational age >20 weeks), analyzed using one of four platforms: R&D Systems, Alere-Triage, Roche-Elecsys or Abbott-Architect. Two merging algorithms, using Z -Score or Multiple of Median (MOM) transformations, were applied. A single Best Reference Curve (BRC), based on merged non-case PlGF concentrations, was constructed. Case-identification performance of the BRC for PlGF was compared to platform-specific curves. Results PlGF concentrations from different analytical platforms were merged ( Z -scores marginally better than MOMs) and, overall, BRC case-identification rates out-performed platform-specific curves. Conclusions Laboratory measurements from different platforms can be standardised and merged to give reference curves from aggregated PlGF datasets. This method allows for analysis of PlGF as a diagnostic marker for preeclampsia and is generalisable to other medical questions, thereby extending the scope of individual studies to answer a variety of important medical questions. Disclosures O. Burke: None. S. Benton: None. P. Szafranski: None. P. von Dadelszen: None. C. Buhimschi: None. I. Cetin: None. L. Chapell: None. F. Figueras: None. A. Galindo: None. I. Herraiz: None. C. Holzman: None. C. Hubel: None. U. Knudsen: None. C. Kronborg: None. H. Laivuori: None. T. McElrath: None. M. Moertl: None. J. Meyers: None. R.B. Ness: None. L. Oliviera: None. G. Olson: None. L. Poston: None. C. Ris-Stalphers: None. J.M. Roberts: None. E. Schistermann: None. E. Steegers: None. H. Stepan: None. O. Lapaire: None. D. Schlembach: None. S. Timmermans: None. V. Tsatsaris: None. J.A. van der Post: None. S. Verlohren: Consultant, Research Support Recipient, Commercial Interest: Roche Diagnostics, ThermoFisher, Novartis. P.M. Villa: None. D. Williams: None. H. Zeisler: None. C. Zhang: None. C.W. Redman: None. A. Staff: None.

Details

ISSN :
22107789
Volume :
5
Database :
OpenAIRE
Journal :
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health
Accession number :
edsair.doi...........17d4787ca0e29529793a31f2ead61f2d
Full Text :
https://doi.org/10.1016/j.preghy.2014.10.098